Katz-Salamon M, Lagercrantz H
Department of Paediatrics, Karolinska Hospital, Stockholm, Sweden.
Arch Dis Child Fetal Neonatal Ed. 1994 Mar;70(2):F90-5. doi: 10.1136/fn.70.2.f90.
The activity of peripheral chemoreceptors was studied in 19 preterm very low birthweight infants at the postconceptional age of 36 and 40 weeks using the hyperoxic test. The infants were in a healthy condition and did not receive any extra oxygen or medication when tested. The inhalation of pure oxygen caused a decrease in mean (SE) ventilation by 16.1 (2.6)% and 15.1 (2.1)% at the 36th and 40th gestational week respectively. At the 36th gestational week the ventilatory response was significantly slower than at 40 weeks (10.9 (6) and 7.3 (3) sec). Six infants who had been on supplemental oxygen for more than 21 days (from 21 to 56 days) responded with significantly lower response to hyperoxia at the 36th gestational week (-7.9 (3.6)%) than those receiving oxygen treatment for a shorter period of time, 0 to 16 days (-19.9 (3.2)%). The 'low responding' group included three infants who had suffered from chronic lung disease. Those infants showed the lowest hyperoxic response (-4.3 (3.9)%). There was no difference in the response among healthy preterm infants (eight infants) and infants with respiratory distress syndrome. At the 40th gestational week the differences, even though showing the same characteristics, were not statistically significant. No statistically significant relationship was found between the strength of the ventilatory response to oxygen versus gestational, postnatal age, nor the time interval between the termination of supplemental oxygen treatment and the test. No relationship was found between the number of apnoeic/bradycardic spells and the strength of the ventilatory depression caused by hyperoxia. In conclusion we found that the very preterm infants, with the exception of those who received long periods of oxygen treatment, have stronger peripheral chemoreceptor responses than those reported for 2-4 day old full term infants. However, infants who had suffered from chronic lung disease show a depressed hyperoxic response.
采用高氧试验,对19例孕龄36周和40周的早产极低出生体重儿的外周化学感受器活性进行了研究。测试时,这些婴儿健康状况良好,未接受任何额外的氧气或药物治疗。吸入纯氧后,孕36周和40周时的平均(标准误)通气量分别下降了16.1(2.6)%和15.1(2.1)%。孕36周时的通气反应明显慢于40周时(分别为10.9(6)秒和7.3(3)秒)。6例接受补充氧气超过21天(21至56天)的婴儿,在孕36周时对高氧的反应明显低于接受氧气治疗时间较短(0至16天)的婴儿(-7.9(3.6)% 比 -19.9(3.2)%)。“低反应”组包括3例患有慢性肺病的婴儿。这些婴儿的高氧反应最低(-4.3(3.9)%)。健康早产婴儿(8例)和患有呼吸窘迫综合征的婴儿之间的反应没有差异。在孕40周时,尽管差异表现出相同的特征,但无统计学意义。未发现对氧气的通气反应强度与孕龄、出生后年龄、补充氧气治疗终止与测试之间的时间间隔存在统计学上的显著关系。未发现呼吸暂停/心动过缓发作次数与高氧引起的通气抑制强度之间存在关系。总之,我们发现,除了那些接受长时间氧气治疗的婴儿外,极早产婴儿的外周化学感受器反应比报道的2至4日龄足月儿更强。然而,患有慢性肺病的婴儿表现出高氧反应降低。